You are not logged in. This means you
CAN ONLY VIEW reports that were published prior to Friday, September 6, 2024. You
MUST UPGRADE YOUR MEMBERSHIP if you want to see any current reports.
AFTER MARKET UPDATE - TUESDAY, MARCH 31ST, 2015
Previous After Market Report Next After Market Report >>>
|
|
|
DOW |
-200.19 |
17,776.12 |
-1.11% |
|
Volume |
948,218,440 |
+44% |
|
Volume |
1,648,298,730 |
+0% |
NASDAQ |
-46.56 |
4,900.88 |
-0.94% |
|
Advancers |
1,254 |
40% |
|
Advancers |
1,104 |
37% |
S&P 500 |
-18.35 |
2,067.89 |
-0.88% |
|
Decliners |
1,797 |
57% |
|
Decliners |
1,770 |
59% |
Russell 2000 |
-5.03 |
1,252.77 |
-0.40% |
|
52 Wk Highs |
120 |
|
|
52 Wk Highs |
79 |
|
S&P 600 |
+8.57 |
720.20 |
+1.20% |
|
52 Wk Lows |
33 |
|
|
52 Wk Lows |
43 |
|
|
|
Major Averages Fell in March
Kenneth J. Gruneisen - Passed the CAN SLIM® Master's Exam
For the month of March, the Dow retreated -2%, the S&P 500 declined -1.7% and the NASDAQ erased -1.3%. For the quarter, the Dow lost -0.3%, while the S&P 500 edged +0.4% higher and the NASDAQ gained +3.5%. Stocks finished Tuesday lower. The Dow lost 200 points to 17,776. The S&P 500 declined 18 points to 2,067. The NASDAQ fell 46 points to 4,900. The volume totals were reported higher on the NYSE and higher on the Nasdaq exchange versus the prior session totals. Decliners led advancers by nearly a 3-2 margin on the NYSE and on the Nasdaq exchange. There were 54 high-ranked companies from the CANSLIM.net Leaders List that made new 52-week highs and appeared on the CANSLIM.net BreakOuts Page, down from the prior session total of 68 stocks. The list of new 52-week highs contracted yet still outnumbered new 52-week lows on the NYSE and the Nasdaq exchange. There were gains for only 2 of the 13 high-ranked companies currently on the Featured Stocks Page.
Concerning the M criteria, the major averages' endured recent distributional pressure which put the rally under pressure, however, their remains a healthy level of leadership (stocks hitting new 52-week highs). New buying efforts should only be made in stocks meeting all of the fundamental and technical guidelines the fact-based investment system.
PICTURED: The Nasdaq Composite Index is consolidating above support at its 50-day moving average (DMA) line and prior highs.
The major averages consolidated on the final trading day of the quarter. Economic data was mixed today. A measure of home prices in January topped projections, while March’s consumer confidence also beat expectations. However, a measure of manufacturing activity in March rose less than anticipated.
At the close, all 10 sectors were lower. Industrials were the notable underperformers, including United Technologies (UTX -1.37%). In health care, GlaxoSmithKline (GSK -2.22%) retreated and Celgene (CELG -3.95%) slid. M&A activity resurfaced, as Charter (CHTR +5.95%) rallied after agreeing to a $10.4 billion acquisition. Similarly, after agreeing to sell a business unit, Johnson Controls (JCI +1.22%) advanced. However, Lorillard finished down (LO -1.61%) and Reynolds American Inc (RAI -0.81%) fell amid rumors of regulatory hurdles to their merger.
Treasuries edged higher. The benchmark 10-year note gained 5/32 to yield 1.93%.
Commodities were mostly lower. WTI crude declined 2.5% to $47.48/barrel and COMEX gold fell 0.1% to $1,183.60/ounce. In FOREX, the dollar rose 0.1% with the euro off 0.8% to $1.0750/EUR and the yen unchanged at ¥120.01/USD.
The Featured Stocks Page shows recent notes and Headline Links directing members to detailed analysis with data-packed graphs annotated by a Certified expert. See the Premium Member Homepage for archives to all prior pay reports published.
|
Kenneth J. Gruneisen started out as a licensed stockbroker in August 1987, a couple of months prior to the historic stock market crash that took the Dow Jones Industrial Average down -22.6% in a single day. He has published daily fact-based fundamental and technical analysis on high-ranked stocks online for two decades. Through FACTBASEDINVESTING.COM, Kenneth provides educational articles, news, market commentary, and other information regarding proven investment systems that work in good times and bad.
Comments contained in the body of this report are technical opinions only and are not necessarily those of Gruneisen Growth Corp. The material herein has been obtained from sources believed to be reliable and accurate, however, its accuracy and completeness cannot be guaranteed. Our firm, employees, and customers may effect transactions, including transactions contrary to any recommendation herein, or have positions in the securities mentioned herein or options with respect thereto. Any recommendation contained in this report may not be suitable for all investors and it is not to be deemed an offer or solicitation on our part with respect to the purchase or sale of any securities. |
|
|
Broad Group Weakness Weighs on Major Averages
Kenneth J. Gruneisen - Passed the CAN SLIM® Master's Exam
Negative action from the Retail Index ($RLX -0.42%), Bank Index ($BKX -0.38%) and the Broker/Dealer Index ($XBD -0.59%) had a bad influence on the major averages on Tuesday. The Biotechnology Index ($BTK -2.14%) led the tech sector's retreat while the Semiconductor Index ($SOX -1.17%) suffered a smaller loss. The Networking Index ($NWX +0.23%) eked out a small gain. The Gold & Silver Index ($XAU -1.53%) was weak along with losses in energy-related shares as the Integrated Oil Index ($XOI -1.05%) and the Oil Services Index ($OSX -0.30%) ended lower.
Charts courtesy www.stockcharts.com
PICTURED: The Bank Index ($BKX -0.38%) is consolidating above its 50-day and 200-day moving average (DMA) lines.
Oil Services |
$OSX |
190.12 |
-0.57 |
-0.30% |
-9.84% |
Integrated Oil |
$XOI |
1,330.63 |
-14.13 |
-1.05% |
-1.30% |
Semiconductor |
$SOX |
695.48 |
-8.26 |
-1.17% |
+1.25% |
Networking |
$NWX |
371.67 |
+0.85 |
+0.23% |
+3.83% |
Broker/Dealer |
$XBD |
188.71 |
-1.12 |
-0.59% |
+2.20% |
Retail |
$RLX |
1,118.79 |
-4.69 |
-0.42% |
+8.33% |
Gold & Silver |
$XAU |
65.50 |
-1.02 |
-1.53% |
-4.77% |
Bank |
$BKX |
72.16 |
-0.27 |
-0.37% |
-2.83% |
Biotech |
$BTK |
3,987.60 |
-87.17 |
-2.14% |
+15.95% |
|
|
|
Pullback Near Previously Stubborn Resistance
Kenneth J. Gruneisen - Passed the CAN SLIM® Master's Exam
Facebook Inc (FB -$0.98 or -1.18% to $82.22) is consolidating above previously stubborn resistance in the $81-82 area. It rallied to new 52 week highs with a streak of volume-driven gains since last shown in this FSU section on 3/11/15 with annotated graphs under the headline, "Relative Strength Rating Fell While Encountering Resistance". Its Relative Strength rating, at 80 now, is right at the 80+ minimum guideline for new buy candidates. Its Relative Strength line (blue jagged line) was plotted much higher in October of last year.
It was highlighted in yellow while perched within close striking distance of its 52-week high in the 2/20/15 mid-day report (read here). With no resistance due to overhead supply it was noted - "Convincing volume-driven gains into new all-time high territory could mark the beginning of another meaningful leg up for this high-ranked Internet - Content firm."
Waning leadership (L criteria) in the Internet - Content industry group was noted as a concern and the group has a C- rating. Bullish action from at least one other company in the group provides some reassurance. The company reported earnings +69% on +49% sales revenues for the Dec '14 quarter. That marked its 7th consecutive quarterly comparison with earnings increasing well above the +25% minimum (C criteria).
Is current Up/Down Volume Ratio of 1.8 is an unbiased indication its shares have been under accumulation over the past 50 days. The high-ranked Internet - Content group leader has seen the number of top-rated funds owning its shares rise from 2,085 in Mar '14 to 2,568 in Dec '14, a reassuring sign concerning the I criteria. Keep in mind that its large supply of 2.21 billion shares in the public float makes it an unlikely sprinter, especially as it is already well known by the institutional crowd and the general public.
|
|
Color Codes Explained :
Y - Better candidates highlighted by our
staff of experts. G - Previously featured
in past reports as yellow but may no longer be buyable under the
guidelines.
***Last / Change / Volume data in this table is the closing quote data***
Symbol/Exchange
Company Name
Industry Group |
PRICE |
CHANGE (%Change) |
Day High |
Volume (% DAV) (% 50 day avg vol) |
52 Wk Hi % From Hi |
Featured Date |
Price Featured |
Pivot Featured |
Max Buy |
ACT
-
NYSE
Actavis plc
Medical-Generic Drugs
|
$297.62
|
-7.14
-2.34% |
$304.80
|
3,551,985 104.72% of 50 DAV
50 DAV is 3,392,000
|
$317.72 -6.33%
|
12/29/2014
|
$260.22
|
PP = $272.85
|
MB = $286.49
|
Most Recent Note - 3/30/2015 7:28:59 PM
G - Consolidating quietly, very extended from any sound base. Completed a new Public Offering on 2/25/15. Reported Dec '14 earnings +23%, below the +25% minimum guideline (C criteria) of the fact-based investment system. Its 50 DMA line ($287) defines support where violations would raise more serious concerns.
>>> FEATURED STOCK ARTICLE : Extended From Base After Completing New Public Offering - 3/13/2015
View all notes |
Set NEW NOTE alert |
CANSLIM.net Company Profile |
SEC
News |
Chart |
Request a new note
C
A N
S L
I M
|
AKAM
-
NASDAQ
Akamai Technologies Inc
INTERNET - Internet Software and Services
|
$71.05
|
-0.86
-1.19% |
$71.72
|
1,329,644 80.68% of 50 DAV
50 DAV is 1,648,000
|
$73.53 -3.38%
|
2/13/2015
|
$68.46
|
PP = $65.49
|
MB = $68.76
|
Most Recent Note - 3/30/2015 7:31:03 PM
G - Consolidating with volume totals cooling. Recent lows highs in the $68.50 area define near-term support above its 50 DMA line.
>>> FEATURED STOCK ARTICLE : Wedging Gains Have Followed Brief Consolidation - 3/23/2015
View all notes |
Set NEW NOTE alert |
CANSLIM.net Company Profile |
SEC
News |
Chart |
Request a new note
C
A N
S L
I M
|
AMBA
-
NASDAQ
Ambarella Inc
ELECTRONICS - Semiconductor - Specialized
|
$75.71
|
+1.10
1.47% |
$77.39
|
2,508,946 131.70% of 50 DAV
50 DAV is 1,905,000
|
$74.74 1.30%
|
3/2/2015
|
$60.54
|
PP = $63.30
|
MB = $66.47
|
Most Recent Note - 3/31/2015 12:12:01 PM
G - Hitting another new high with today's gain, getting very extended. Prior highs near $63 define important near term support to watch on pullbacks. See the latest FSU analysis for more details and new annotated graphs.
>>> FEATURED STOCK ARTICLE : Getting Extended After Brief Pullback - 3/30/2015
View all notes |
Set NEW NOTE alert |
CANSLIM.net Company Profile |
SEC
News |
Chart |
Request a new note
C
A N
S L
I M
|
EPAM
-
NYSE
Epam Systems Inc
COMPUTER SOFTWARE and SERVICES - Information Technology Service
|
$61.29
|
-0.94
-1.51% |
$62.22
|
341,901 96.58% of 50 DAV
50 DAV is 354,000
|
$63.50 -3.48%
|
3/27/2015
|
$61.97
|
PP = $63.60
|
MB = $66.78
|
Most Recent Note - 3/27/2015 5:40:31 PM
Y - Color code is changed to yellow with new pivot point cited based on its 2/27/15 high while building a short flat base. Subsequent volume-driven gains above the pivot point may trigger a new (or add-on) technical buy signal. Stubbornly holding its ground well above prior highs and its 50 DMA line defining support to watch on pullbacks.
>>> FEATURED STOCK ARTICLE : Hovering Near Highs Extended From Prior Base - 3/18/2015
View all notes |
Set NEW NOTE alert |
CANSLIM.net Company Profile |
SEC
News |
Chart |
Request a new note
C
A N
S L
I M
|
FB
-
NASDAQ
Facebook Inc Cl A
INTERNET
|
$82.22
|
-0.98
-1.18% |
$83.50
|
19,708,024 73.90% of 50 DAV
50 DAV is 26,667,000
|
$86.07 -4.48%
|
2/20/2015
|
$81.79
|
PP = $78.47
|
MB = $82.39
|
Most Recent Note - 3/31/2015 6:13:14 PM
G - Consolidating above prior resistance in the $82 area defining important near-term support above the 50 DMA line. See the latest FSU analysis for more details and new annotated graphs.
>>> FEATURED STOCK ARTICLE : Pullback Near Previously Stubborn Resistance - 3/31/2015
View all notes |
Set NEW NOTE alert |
CANSLIM.net Company Profile |
SEC
News |
Chart |
Request a new note
C
A N
S L
I M
|
Symbol/Exchange
Company Name
Industry Group |
PRICE |
CHANGE (%Change) |
Day High |
Volume (% DAV) (% 50 day avg vol) |
52 Wk Hi % From Hi |
Featured Date |
Price Featured |
Pivot Featured |
Max Buy |
ILMN
-
NASDAQ
Illumina Inc
DRUGS - Biotechnology
|
$185.64
|
-1.98
-1.06% |
$187.34
|
1,145,594 103.42% of 50 DAV
50 DAV is 1,107,700
|
$213.33 -12.98%
|
12/30/2014
|
$186.26
|
PP = $196.00
|
MB = $205.80
|
Most Recent Note - 3/30/2015 7:35:16 PM
G - Halted its slide at its 200 DMA line but recent gains have lacked great volume conviction. Its Relative Strength rating has slumped to 73, below the 80+ minimum guideline for buy candidates. Needs gains above the 50 DMA line for its outlook to improve.
>>> FEATURED STOCK ARTICLE : Relative Strength Rating Falls While Testing 200-Day Average - 3/25/2015
View all notes |
Set NEW NOTE alert |
CANSLIM.net Company Profile |
SEC
News |
Chart |
Request a new note
C
A N
S L
I M
|
JLL
-
NYSE
Jones Lang Lasalle Inc
REAL ESTATE - Property Management/Developmen
|
$170.40
|
+1.29
0.76% |
$170.80
|
418,247 137.58% of 50 DAV
50 DAV is 304,000
|
$170.85 -0.26%
|
2/3/2015
|
$156.95
|
PP = $154.66
|
MB = $162.39
|
Most Recent Note - 3/30/2015 7:38:38 PM
G - It is extended from its prior base and found support above prior highs on the recent pullback. The 50 DMA line ($159) defines the next important support level to watch.
>>> FEATURED STOCK ARTICLE : Found Support Near Prior Highs and 50-Day Moving Average Line - 3/17/2015
View all notes |
Set NEW NOTE alert |
CANSLIM.net Company Profile |
SEC
News |
Chart |
Request a new note
C
A N
S L
I M
|
LNKD
-
NYSE
Linkedin Corp Class A
INTERNET - Internet Information Providers
|
$249.86
|
-5.33
-2.09% |
$255.37
|
1,104,931 73.66% of 50 DAV
50 DAV is 1,500,000
|
$276.18 -9.53%
|
2/6/2015
|
$269.83
|
PP = $243.35
|
MB = $255.52
|
Most Recent Note - 3/30/2015 7:48:37 PM
G - Quietly slumped below prior lows and it is testing its 50 DMA line ($253.29) defining near-term support. Stalled and made no progress since the considerable "breakaway gap" noted in the 2/06/15 mid-day report (read here).
>>> FEATURED STOCK ARTICLE : Stalled Following "Breakaway Gap" 6 Weeks Ago - 3/19/2015
View all notes |
Set NEW NOTE alert |
CANSLIM.net Company Profile |
SEC
News |
Chart |
Request a new note
C
A N
S L
I M
|
NXPI
-
NASDAQ
Nxp Semiconductors N V
ELECTRONICS - Semiconductor - Broad Line
|
$100.36
|
-2.07
-2.02% |
$102.55
|
2,526,401 64.35% of 50 DAV
50 DAV is 3,926,000
|
$108.50 -7.50%
|
1/5/2015
|
$76.43
|
PP = $78.44
|
MB = $82.36
|
Most Recent Note - 3/30/2015 7:40:48 PM
G - It is very extended from its prior base, and disciplined investors avoid chasing extended stocks. Recent lows ($93.05 on 3/26/15) and the 50 DMA line ($89.97) define important near-term support to watch on pullbacks.
>>> FEATURED STOCK ARTICLE : Pullback Following Considerable Rally of 41.9% Since Start of Year - 3/26/2015
View all notes |
Set NEW NOTE alert |
CANSLIM.net Company Profile |
SEC
News |
Chart |
Request a new note
C
A N
S L
I M
|
PANW
-
NYSE
Palo Alto Networks
Computer Sftwr-Security
|
$146.08
|
-2.53
-1.70% |
$148.39
|
1,706,916 124.23% of 50 DAV
50 DAV is 1,374,000
|
$150.44 -2.90%
|
3/27/2015
|
$146.44
|
PP = $149.45
|
MB = $156.92
|
Most Recent Note - 3/30/2015 7:43:31 PM
Y - Hit a new high (N criteria) with today's gain backed by only +28% above average volume. Members were recently reminded - "Stocks should have at least +40% above average volume while rising above the pivot point to clinch a proper new (or add-on) technical buy signal."
>>> FEATURED STOCK ARTICLE : Latest Consolidation is a Short New "Square Box" Base - 3/27/2015
View all notes |
Set NEW NOTE alert |
CANSLIM.net Company Profile |
SEC
News |
Chart |
Request a new note
C
A N
S L
I M
|
Symbol/Exchange
Company Name
Industry Group |
PRICE |
CHANGE (%Change) |
Day High |
Volume (% DAV) (% 50 day avg vol) |
52 Wk Hi % From Hi |
Featured Date |
Price Featured |
Pivot Featured |
Max Buy |
QLYS
-
NASDAQ
Qualys Inc
Computer Sftwr-Security
|
$46.48
|
-0.22
-0.47% |
$47.80
|
286,530 71.63% of 50 DAV
50 DAV is 400,000
|
$50.00 -7.04%
|
2/6/2015
|
$42.24
|
PP = $40.84
|
MB = $42.88
|
Most Recent Note - 3/30/2015 7:20:19 PM
G - Its 50 DMA line ($43.92) and prior lows in the $42 area define near-term support to watch. More damaging losses would raise concerns.
>>> FEATURED STOCK ARTICLE : Consolidating Above Support at Prior Highs and 50-Day Moving Average - 3/20/2015
View all notes |
Set NEW NOTE alert |
CANSLIM.net Company Profile |
SEC
News |
Chart |
Request a new note
C
A N
S L
I M
|
REIS
-
NASDAQ
Reis Inc
Real Estate Dvlpmt/Ops
|
$25.64
|
-1.89
-6.87% |
$27.28
|
193,372 716.19% of 50 DAV
50 DAV is 27,000
|
$28.82 -11.03%
|
3/16/2015
|
$25.65
|
PP = $26.64
|
MB = $27.97
|
Most Recent Note - 3/31/2015 1:13:08 PM
Y - Down on higher volume today - action indicative of distributional pressure. Hit a new 52-week high and rallied above its pivot point but with volume only +28% above average on the prior session. No resistance remains due to overhead supply. Gains above the pivot point must have at least +40% above average volume to trigger a convincing technical buy signal. Pyramiding is a tactic taught in the Certification that allows investors to let market action help to dictate entries and weighting into each new position purchased.
>>> FEATURED STOCK ARTICLE : Found Support at Long-Term Average and Fundamentals Are Good - 3/16/2015
View all notes |
Set NEW NOTE alert |
CANSLIM.net Company Profile |
SEC
News |
Chart |
Request a new note
C
A N
S L
I M
|
VRX
-
NYSE
Valeant Pharmaceuticals
DRUGS - Drug Manufacturers - Other
|
$198.62
|
-2.76
-1.37% |
$201.49
|
1,542,068 47.16% of 50 DAV
50 DAV is 3,270,000
|
$206.84 -3.97%
|
1/5/2015
|
$144.84
|
PP = $149.90
|
MB = $157.40
|
Most Recent Note - 3/30/2015 7:46:10 PM
G - Completed a new Public Offering on 3/17/15 while consolidating near its all-time high. Earnings for Dec '14 quarter raised concerns. Its recent low ($186.20 on 3/11/15) and its 50 DMA line ($182.27) define near-term support to watch.
>>> FEATURED STOCK ARTICLE : Fundamental Concerns Raised by Weaker Earnings and Sales Increases - 3/24/2015
View all notes |
Set NEW NOTE alert |
CANSLIM.net Company Profile |
SEC
News |
Chart |
Request a new note
C
A N
S L
I M
|
|
|
|
THESE ARE NOT BUY RECOMMENDATIONS!
Comments contained in the body of this report are technical
opinions only. The material herein has been obtained
from sources believed to be reliable and accurate, however,
its accuracy and completeness cannot be guaranteed.
This site is not an investment advisor, hence it does
not endorse or recommend any securities or other investments.
Any recommendation contained in this report may not
be suitable for all investors and it is not to be deemed
an offer or solicitation on our part with respect to
the purchase or sale of any securities. All trademarks,
service marks and trade names appearing in this report
are the property of their respective owners, and are
likewise used for identification purposes only.
This report is a service available
only to active Paid Premium Members.
You may opt-out of receiving report notifications
at any time. Questions or comments may be submitted
by writing to Premium Membership Services 665 S.E. 10 Street, Suite 201 Deerfield Beach, FL 33441-5634 or by calling 1-800-965-8307
or 954-785-1121.
|
|
|